Teladoc Health Price to Sales Ratio 2014-2025 | TDOC
Historical PS ratio values for Teladoc Health (TDOC) over the last 10 years. The current P/S ratio for Teladoc Health as of January 14, 2026 is .
| Teladoc Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-01-14 | 6.61 | 0.46 | |
| 2025-09-30 | 7.73 | $14.50 | 0.53 |
| 2025-06-30 | 8.71 | $14.70 | 0.59 |
| 2025-03-31 | 7.96 | $14.88 | 0.54 |
| 2024-12-31 | 9.09 | $15.12 | 0.60 |
| 2024-09-30 | 9.18 | $15.37 | 0.60 |
| 2024-06-30 | 9.78 | $15.64 | 0.63 |
| 2024-03-31 | 15.10 | $15.84 | 0.95 |
| 2023-12-31 | 21.55 | $15.85 | 1.36 |
| 2023-09-30 | 18.59 | $15.78 | 1.18 |
| 2023-06-30 | 25.32 | $15.57 | 1.63 |
| 2023-03-31 | 25.90 | $15.26 | 1.70 |
| 2022-12-31 | 23.65 | $14.92 | 1.58 |
| 2022-09-30 | 25.35 | $14.50 | 1.75 |
| 2022-06-30 | 33.21 | $14.00 | 2.37 |
| 2022-03-31 | 72.13 | $13.55 | 5.32 |
| 2021-12-31 | 91.82 | $13.01 | 7.06 |
| 2021-09-30 | 126.81 | $13.71 | 9.25 |
| 2021-06-30 | 166.29 | $13.90 | 11.97 |
| 2021-03-31 | 181.75 | $13.82 | 13.15 |
| 2020-12-31 | 199.96 | $13.31 | 15.03 |
| 2020-09-30 | 219.24 | $11.25 | 19.49 |
| 2020-06-30 | 190.84 | $9.71 | 19.66 |
| 2020-03-31 | 155.01 | $8.37 | 18.51 |
| 2019-12-31 | 83.72 | $7.72 | 10.84 |
| 2019-09-30 | 67.72 | $7.41 | 9.14 |
| 2019-06-30 | 66.41 | $7.12 | 9.33 |
| 2019-03-31 | 55.60 | $6.80 | 8.17 |
| 2018-12-31 | 49.57 | $6.44 | 7.69 |
| 2018-09-30 | 86.35 | $5.97 | 14.46 |
| 2018-06-30 | 58.05 | $5.56 | 10.44 |
| 2018-03-31 | 40.30 | $4.87 | 8.27 |
| 2017-12-31 | 34.85 | $4.25 | 8.21 |
| 2017-09-30 | 33.15 | $3.74 | 8.87 |
| 2017-06-30 | 34.70 | $3.23 | 10.75 |
| 2017-03-31 | 25.00 | $3.10 | 8.08 |
| 2016-12-31 | 16.50 | $2.97 | 5.55 |
| 2016-09-30 | 18.31 | $3.22 | 5.68 |
| 2016-06-30 | 16.02 | $3.07 | 5.21 |
| 2016-03-31 | 9.60 | $10.10 | 0.95 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.173B | $2.570B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.076B | 30.86 |
| HCA Healthcare (HCA) | United States | $109.268B | 18.09 |
| CVS Health (CVS) | United States | $100.704B | 11.58 |
| Elevance Health (ELV) | United States | $82.860B | 12.15 |
| Cencora (COR) | United States | $67.884B | 21.88 |
| Natera (NTRA) | United States | $33.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $21.720B | 16.56 |
| Medpace Holdings (MEDP) | United States | $17.364B | 43.11 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.188B | 0.00 |
| Viatris (VTRS) | United States | $15.146B | 5.64 |
| ICON (ICLR) | Ireland | $14.921B | 14.81 |
| BioMerieux (BMXMF) | France | $14.304B | 0.00 |
| Solventum (SOLV) | United States | $13.884B | 13.48 |
| Revvity (RVTY) | United States | $12.644B | 23.28 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.650B | 20.51 |
| Avantor (AVTR) | United States | $8.441B | 12.90 |
| Sonic Healthcare (SKHHY) | Australia | $7.636B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.454B | 0.00 |
| HealthEquity (HQY) | United States | $7.313B | 27.35 |
| BrightSpring Health Services (BTSG) | United States | $6.935B | 41.34 |
| PACS (PACS) | United States | $6.185B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $6.135B | 40.28 |
| Sotera Health (SHC) | United States | $5.452B | 26.29 |
| Alignment Healthcare (ALHC) | United States | $4.351B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.022B | 53.08 |
| Concentras Parent (CON) | United States | $2.619B | 16.34 |
| Progyny (PGNY) | United States | $2.252B | 44.27 |
| Organon (OGN) | United States | $2.238B | 2.36 |
| Surgery Partners (SGRY) | United States | $1.993B | 25.68 |
| Establishment Labs Holdings (ESTA) | United States | $1.923B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.891B | 11.29 |
| Ardent Health (ARDT) | United States | $1.244B | 4.06 |
| Nutex Health (NUTX) | United States | $1.173B | 8.97 |
| CareDx (CDNA) | United States | $1.045B | 17.08 |
| GoodRx Holdings (GDRX) | United States | $0.933B | 15.28 |
| Omada Health (OMDA) | United States | $0.898B | 0.00 |
| Embecta (EMBC) | United States | $0.755B | 4.29 |
| InnovAge Holding (INNV) | United States | $0.752B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.733B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.547B | 24.55 |
| CryoPort (CYRX) | United States | $0.545B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.481B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 8.40 |
| Agilon Health (AGL) | United States | $0.402B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.52 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.279B | 0.00 |
| So-Young (SY) | China | $0.272B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.255B | 53.65 |
| KindlyMD (NAKA) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| LifeMD (LFMD) | United States | $0.185B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |